61.33
price down icon0.89%   -0.55
after-market 시간 외 거래: 61.65 0.32 +0.52%
loading
전일 마감가:
$61.88
열려 있는:
$61.53
하루 거래량:
484.16K
Relative Volume:
0.71
시가총액:
$3.90B
수익:
$136.86M
순이익/손실:
$-168.69M
주가수익비율:
-21.83
EPS:
-2.81
순현금흐름:
$-113.49M
1주 성능:
-1.65%
1개월 성능:
-5.96%
6개월 성능:
-1.14%
1년 성능:
+67.20%
1일 변동 폭
Value
$60.32
$61.78
1주일 범위
Value
$58.71
$63.66
52주 변동 폭
Value
$35.56
$68.58

Rhythm Pharmaceuticals Inc Stock (RYTM) Company Profile

Name
명칭
Rhythm Pharmaceuticals Inc
Name
전화
857-264-4280
Name
주소
222 BERKELEY STREET, BOSTON, MA
Name
직원
283
Name
트위터
@rhythmpharma
Name
다음 수익 날짜
2024-11-05
Name
최신 SEC 제출 서류
Name
RYTM's Discussions on Twitter

RYTM을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
RYTM
Rhythm Pharmaceuticals Inc
61.33 3.97B 136.86M -168.69M -113.49M -2.81
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Rhythm Pharmaceuticals Inc Stock (RYTM) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-07 업그레이드 BofA Securities Neutral → Buy
2025-03-05 재개 Stifel Buy
2025-01-02 개시 Jefferies Buy
2024-12-20 개시 Oppenheimer Outperform
2024-10-21 개시 Guggenheim Buy
2024-09-18 개시 H.C. Wainwright Buy
2024-09-17 개시 JMP Securities Mkt Outperform
2024-05-08 다운그레이드 BofA Securities Buy → Neutral
2023-12-19 업그레이드 Morgan Stanley Equal-Weight → Overweight
2023-08-01 업그레이드 BofA Securities Neutral → Buy
2023-01-18 재개 Canaccord Genuity Buy
2022-08-08 업그레이드 Goldman Neutral → Buy
2022-08-05 업그레이드 BofA Securities Underperform → Neutral
2022-06-17 재확인 Needham Buy
2022-03-02 재개 Stifel Buy
2022-02-17 업그레이드 Ladenburg Thalmann Neutral → Buy
2021-12-08 개시 Wells Fargo Overweight
2021-11-19 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2021-09-14 재개 Goldman Neutral
2021-08-04 다운그레이드 BofA Securities Neutral → Underperform
2021-08-04 다운그레이드 Ladenburg Thalmann Buy → Neutral
2020-11-30 다운그레이드 BofA Securities Buy → Neutral
2020-01-08 개시 Goldman Sell
2019-07-12 업그레이드 Stifel Hold → Buy
2019-07-08 개시 Canaccord Genuity Buy
2019-03-13 개시 Ladenburg Thalmann Buy
2018-09-07 재개 Morgan Stanley Overweight
2018-06-25 재확인 Needham Buy
2018-06-15 재확인 Needham Buy
2017-10-30 개시 BofA/Merrill Buy
2017-10-30 개시 Needham Buy
모두보기

Rhythm Pharmaceuticals Inc 주식(RYTM)의 최신 뉴스

pulisher
May 30, 2025

Rhythm Pharmaceuticals (RYTM) Gets Price Target Upgrade by Stifel Amid Obesity Drug Optimism - Insider Monkey

May 30, 2025
pulisher
May 30, 2025

Stifel Nicolaus Issues Positive Forecast for Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock Price - Defense World

May 30, 2025
pulisher
May 29, 2025

12 Analysts Assess Rhythm Pharmaceuticals: What You Need To Know - Benzinga

May 29, 2025
pulisher
May 29, 2025

Rhythm Pharmaceuticals (RYTM) Target Price Raised by Stifel Analyst | RYTM Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Rhythm Pharmaceuticals (RYTM) Stock Jumps Nearly 6%: What's Driving the Upbeat Tempo? - Daily Chhattisgarh News

May 29, 2025
pulisher
May 29, 2025

Rhythm Pharmaceuticals (RYTM) Target Price Boosted by Analyst | - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Rhythm Pharmaceuticals (RYTM) Target Price Boosted by Analyst | RYTM Stock News - GuruFocus

May 29, 2025
pulisher
May 28, 2025

Ameriprise Financial Inc. Purchases 11,480 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World

May 28, 2025
pulisher
May 27, 2025

POMC Deficiency Obesity Market on Track for Major Expansion - openPR.com

May 27, 2025
pulisher
May 24, 2025

(RYTM) Investment Analysis - news.stocktradersdaily.com

May 24, 2025
pulisher
May 22, 2025

Deutsche Bank AG Has $2.73 Million Position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World

May 22, 2025
pulisher
May 21, 2025

Gotham Asset Management LLC Sells 2,685 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World

May 21, 2025
pulisher
May 21, 2025

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives $75.38 Consensus Price Target from Analysts - Defense World

May 21, 2025
pulisher
May 14, 2025

Rhythm Pharmaceuticals Announces New Data Presentations on Patie - GuruFocus

May 14, 2025
pulisher
May 14, 2025

(RYTM) On The My Stocks Page - news.stocktradersdaily.com

May 14, 2025
pulisher
May 14, 2025

RYTM Shows Positive Results in Hypothalamic Obesity Treatment | - GuruFocus

May 14, 2025
pulisher
May 14, 2025

RYTM Shows Positive Results in Hypothalamic Obesity Treatment | RYTM Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Rhythm Pharmaceuticals Announces New Data Presentations on Patients with Acquired or Congenital Hypothalamic Obesity (N=35) Treated with Setmelanotide for up to Nine Months in French Early-access Program - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

New Clinical Data: Rhythm's Obesity Drug Achieves 23% Weight Loss in Real-World Study, FDA Filing Coming Q3 - Stock Titan

May 14, 2025
pulisher
May 13, 2025

Raymond James Financial Inc. Buys New Shares in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World

May 13, 2025
pulisher
May 12, 2025

Rhythm pharmaceuticals outlines Q3 2025 filing for acquired hypothalamic obesity treatment - MSN

May 12, 2025
pulisher
May 12, 2025

HC Wainwright Has Negative Estimate for RYTM Q2 Earnings - Defense World

May 12, 2025
pulisher
May 09, 2025

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q1 2025 Earnings Call Transcript - Insider Monkey

May 09, 2025
pulisher
May 09, 2025

Rhythm Pharmaceuticals (NASDAQ:RYTM) Trading Down 6.6% on Disappointing Earnings - Defense World

May 09, 2025
pulisher
May 09, 2025

Needham & Company LLC Increases Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target to $72.00 - Defense World

May 09, 2025
pulisher
May 09, 2025

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Lags Revenue Estimates - MSN

May 09, 2025
pulisher
May 08, 2025

Rhythm Pharmaceuticals Inc (RYTM) Q1 2025 Earnings Call Highlights: Strong IMCIVREE Sales and ... - Yahoo Finance

May 08, 2025
pulisher
May 07, 2025

Rhythm Pharmaceuticals Q1 2025 slides: Revenue grows 45% as HO program advances - Investing.com Canada

May 07, 2025
pulisher
May 07, 2025

RHYTHM PHARMACEUTICALS, INC. SEC 10-Q Report - TradingView

May 07, 2025
pulisher
May 07, 2025

Rhythm Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (15 Ratings) - Benzinga

May 07, 2025
pulisher
May 07, 2025

Rhythm Pharmaceuticals (RYTM) Price Target Raised by Needham | RYTM Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Rhythm Pharmaceuticals Q1 2025 Earnings Call Transcript - MarketBeat

May 07, 2025
pulisher
May 07, 2025

Earnings call transcript: Rhythm Pharmaceuticals misses Q1 2025 EPS estimates - Investing.com

May 07, 2025
pulisher
May 07, 2025

Rhythm Pharmaceuticals' Q1 Net Loss Narrows, Revenue Increases - marketscreener.com

May 07, 2025
pulisher
May 07, 2025

RYTM Misses Q1 Revenue Estimates, Focuses on Future Therapies for Hypothalamic Obesity | RYTM Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Rhythm Pharmaceuticals Reports Q1 2025 Earnings: EPS of ($0.81) Misses Estimate, Revenue of $37.7 Million Below Expectations - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Rhythm Pharmaceuticals Reports First Quarter 2025 Financial Results and Business Update - The Manila Times

May 07, 2025
pulisher
May 07, 2025

Earnings Flash (RYTM) Rhythm Pharmaceuticals Posts Q1 Loss $0.81, vs. FactSet Est of $0.73 Loss - marketscreener.com

May 07, 2025
pulisher
May 07, 2025

BRIEF-Rhythm Pharmaceuticals Q1 Net Income USD -49.498 Million - TradingView

May 07, 2025
pulisher
May 06, 2025

Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences - The Manila Times

May 06, 2025
pulisher
May 06, 2025

Rare Disease Leader Rhythm Pharmaceuticals Lines Up Triple Conference Appearances in Healthcare Circuit - Stock Titan

May 06, 2025
pulisher
May 06, 2025

Mariner LLC Invests $254,000 in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World

May 06, 2025
pulisher
May 05, 2025

Rhythm Pharmaceuticals (RYTM) Expected to Announce Earnings on Wednesday - Defense World

May 05, 2025
pulisher
May 04, 2025

Rhythm Pharmaceuticals, Inc.'s (NASDAQ:RYTM) Shares Climb 36% But Its Business Is Yet to Catch Up - simplywall.st

May 04, 2025
pulisher
May 04, 2025

(RYTM) Trading Report - news.stocktradersdaily.com

May 04, 2025
pulisher
Apr 30, 2025

BlackRock, Inc. Reduces Stake in Rhythm Pharmaceuticals Inc - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

Will Rhythm Pharmaceuticals, Inc. (RYTM) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance

Apr 30, 2025
pulisher
Apr 30, 2025

Obesity Market Set to Grow Substantially Through 2034, - openPR.com

Apr 30, 2025
pulisher
Apr 26, 2025

Rhythm Pharmaceuticals (RYTM) Moves 5.2% Higher: Will This Strength Last? - MSN

Apr 26, 2025
pulisher
Apr 26, 2025

Wells Fargo & Company MN Boosts Stake in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World

Apr 26, 2025
pulisher
Apr 26, 2025

Brokerages Set Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Target Price at $74.92 - Defense World

Apr 26, 2025

Rhythm Pharmaceuticals Inc (RYTM) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
자본화:     |  볼륨(24시간):